New Trade Agreement Means More Jobs

New Trade Agreement Means More Jobs

10.13.11 | By Jay Taylor

Yesterday, Congress - with an unusually high level of bi-partisan support - passed the Korea-U.S. Free Trade Agreement. PhRMA has supported this effort for a long time and thinks that the transparency, ethical business practices and intellectual property provisions achieved in the agreement represent a good baseline for other agreements now under consideration - such as the Trans-Pacific Partnership.
One key benefit of the agreement is that increased U.S. exports - especially from the biopharmaceutical research sector - can mean more highly skilled, high-wage jobs here in the U.S.
For a closer look at PhRMA's take on this important trade development, visit PhRMA's release and information sheet.
Jay Taylor is a Vice President of International at PhRMA.

More On PhRMA — powered by PhRMApedia


Cost in Context